{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:13:36Z","timestamp":1791328416417,"version":"4.3.1"},"reference-count":30,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T00:00:00Z","timestamp":1288310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Paediatrica"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The inhibitory transmitter GABA has been suggested to play an important role in infantile autistic syndrome (IAS), and extensive investigations suggest that excitatory actions of GABA in neurological disorders are because of a persistent increase of [Cl<jats:sup>\u2212<\/jats:sup>]<jats:sub>I<\/jats:sub>.<\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> To test the effects of the chloride co\u2010transporter NKCC1 diuretic compound Bumetanide that reduces [Cl<jats:sup>\u2212<\/jats:sup>]<jats:sub>I<\/jats:sub> on IAS.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Bumetanide was administered daily (1\u2003mg daily) during a 3\u2003\u2010month period and clinical and biological tests made. We used 5 standard IAS severity tests \u2010 Childhood Autism Rating Scale, Aberrant Behaviour Checklist, Clinical Global Impressions; Repetitive and Restrictive Behaviour and the Regulation Disorder Evaluation Grid.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> We report a significant improvement in IAS with no side effects.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Bumetanide decreases autistic behaviour with no side effects suggesting that diuretic agents may exert beneficial effects on IAS and that alterations of the actions of GABA may be efficient in IAS treatment calling for large scale randomized trials.<\/jats:p>","DOI":"10.1111\/j.1651-2227.2010.01933.x","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T17:28:24Z","timestamp":1278437304000},"page":"1885-1888","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":136,"title":["The diuretic bumetanide decreases autistic behaviour in five infants treated during 3\u2003months with no side effects"],"prefix":"10.1111","volume":"99","author":[{"given":"Eric","family":"Lemonnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehezkel","family":"Ben\u2010Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,10,29]]},"reference":[{"key":"e_1_2_7_2_2","volume-title":"Diagnostic Criteria for Research","author":"World Health Organisation","year":"1994"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/dev.1036"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-4388(02)00299-4"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2006.05.010"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00017.2006"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/neu.480220702"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/16697"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076510"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2005.09.026"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1301"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.90761.2008"},{"key":"e_1_2_7_13_2","first-page":"R1","article-title":"Elevated plasma gamma\u2010aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism","volume":"8","author":"Dhossche D","year":"2002","journal-title":"Med Sci Monit"},{"key":"e_1_2_7_14_2","first-page":"133","article-title":"Theoretical aspects of the study of benzodiazepine receptors in infantile autism","volume":"56","author":"Garreau B","year":"1993","journal-title":"Acta Paedopsychiatr"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb05662.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.physiol.64.081501.155847"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90197-6"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172145"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199311000-00023"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02172092"},{"key":"e_1_2_7_21_2","unstructured":"Rog\u00e9B.Echelle d\u2019\u00e9valuation de l\u2019autisme infantile\u2010version traduite (CARS\u2010T). EAP\/ECPA.1989; Ref Type: Generic"},{"key":"e_1_2_7_22_2","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman MG","year":"1985","journal-title":"Am J Ment Defic"},{"key":"e_1_2_7_23_2","unstructured":"BouvardM.Liste des comportements aberrants\u2010 version traduite. EAP\/ECPA.2000; Ref Type: Generic"},{"key":"e_1_2_7_24_2","unstructured":"GuyW.Assessment Manual for psychopharmacology. Early Clinical Drug Evaluation Unit.2000. National institute of Mental Health. Ref Type: Generic"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-009-0028-5"},{"key":"e_1_2_7_26_2","unstructured":"DosscheDM.GABA in autism. international review of neurobiology 71 1\u2010481.2005. Amsterdam:Academic Press. Ref Type: Generic."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19980401)76:4<327::AID-AJMG8>3.0.CO;2-M"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1133212"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0910249107"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050166"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2008.09.002"}],"container-title":["Acta Paediatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1651-2227.2010.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1651-2227.2010.01933.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T22:20:38Z","timestamp":1697408438000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1651-2227.2010.01933.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,29]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1651-2227.2010.01933.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01933.x","archive":["Portico"],"relation":{},"ISSN":["0803-5253","1651-2227"],"issn-type":[{"value":"0803-5253","type":"print"},{"value":"1651-2227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,29]]},"assertion":[{"value":"2010-10-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}